secwatch.observer — SEC 8-K summary
======================================

Issuer:     Invivyd, Inc. (IVVD)
CIK:        0001832038
Form:       8-K
Filed at:   2023-07-27T23:59:59+00:00
Accession:  0001193125-23-196086
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Invivyd appoints Sara Cotter to Board; option for 100,000 shares
----------------------------------------------------------------

- Sara Cotter appointed to Board effective July 25, 2023, increasing board size from 8 to 9.
- Cotter receives $40,000 annual cash retainer and nonqualified option for 100,000 shares vesting over 3 years.
- Cotter is Portfolio Manager for UBS Global Biotech Lux Fund and former CEO of Levo Therapeutics.
- Company advancing lead candidate VYD222; initial Phase 1 data positive and pivotal trial planned.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832038/000119312523196086/0001193125-23-196086-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832038/000119312523196086/d875161d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-196086

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer